As the health authority Folkhälsomyndigheten announced on Friday, 89 percent of people over 65 years of age – the population group that mainly received Astrazeneca in Sweden – are now fully vaccinated. For this reason, the authority has now decided to end the distribution of the preparation to the individual regions of the Scandinavian EU country and thus gradually stop using the product.
The regions that still have Astrazeneca vaccine in stock can therefore either use it or the funds from Biontech / Pfizer and Moderna. A part of the remaining Astrazeneca cans is to be donated.
At the same time, people over the age of 65 in the Stockholm region will soon be able to choose whether they want the remaining Astrazeneca cans or whether they prefer Pfizer / Biontech or Moderna. The hope is that more older people will decide to be fully vaccinated, as the region announced.
According to Folkhälsomyndigheten, around 75 percent of all adults in Sweden have received at least one corona vaccination so far. More than 47 percent have already received their second dose.